Edward Neugeboren

Edward A. Neugeboren was the founder of Ledgemont Securities LLC, founded in 1999, where the title held was Managing Director from 1999 to 2013.
Mr. Neugeboren was the founder of Ledgemont Capital Group LLC, founded in 1999, holding the title of Co-Managing Director from 1999 to 2013.
Mr. Neugeboren is the founder of Quadview Healthcare Advisors LLC, founded in 2013, with the title of Managing Partner from 2013 to 2015.
Mr. Neugeboren is also the founder of Ledgemont Private Equity..
Mr. Neugeboren is currently Chief Strategy Officer at Cronus Pharma LLC since 2016.
Mr. Neugeboren is currently Independent Director at Grace Therapeutics, Inc. since 2023.
Mr. Neugeboren is currently Independent Director at Matinas BioPharma Holdings, Inc. starting 2025.
Former positions include Director at Elite Pharmaceuticals, Inc. and KineMed, Inc. Deputy Director-Equity Research at UBS Warburg, Inc. from 1995 to 1998.
Managing Director at Ridge Capital Management LLC.
Analyst at Dillon, Read & Co., Inc. from 1995 to 1997.
Analyst at Furman Selz LLC.
Chief Administrative Officer at Lehman Brothers (Market-Maker) from 1998 to 2000.
Analyst at Kidder, Peabody & Co., Inc. from 1993 to 1995.
Chief Strategy Officer at Rising Pharmaceuticals, Inc. Advisor at Healthcare Capital Corp.
(Delaware).
Principal at Arclight Advisors LLC.
Chief Strategy Officer at Casper Pharma LLC from 2016 to 2021.
Education includes an undergraduate degree from Union College (New York), conferred in 1992.